Clinical Trials for Metastatic Breast Cancer

Clinical trials are research studies in which people agree to try new therapies (under careful supervision) in order to help doctors identify the best treatments with the fewest side effects. These studies help improve the overall standard of care.

According to the American Cancer Society, a shortage of people taking part in clinical trials is the biggest reason trials aren’t done. It’s estimated that fewer than 5% of adults diagnosed with cancer will take part in a clinical trial. Why? One factor is that information about current trials and how to enroll in a trial are often not well understood.

In October 2014, the Metastatic Breast Cancer Alliance, of which is a member, released an extensive landscape analysis report covering the current state of research, quality of life in patients, available information and support services, metastatic breast cancer incidence and survival rates, and public awareness. According to their findings, women with metastatic breast cancer often do want to enroll in clinical trials so that they can try new treatments that might extend their lives. However, these women also say they are not often told about clinical trials for new treatments, especially if the trials are being done outside of their hospital. Those who do participate often say that they were motivated by their doctors to enroll.

Read about the experiences of Community members in Seven Things People With Metastatic Breast Cancer Want You to Know About Joining a Clinical Trial.

Clinical trials are an important step in discovering new treatments for breast cancer and other diseases as well as new ways to detect, diagnose, and reduce the risk of disease. Clinical trials show researchers what does and doesn’t work in peop…

Full credit to the source URL for this article; please feel free to follow the link through to the full article.

Leave a Comment

You must be logged in to post a comment.